Pyle L - Search Results

1

Axitinib for the treatment of metastatic renal cell carcinoma: recommendations for therapy management to optimize outcomes.

Larkin J, Fishman M, Wood L, Negrier S, Olivier K, Pyle L, Gorbunova V, Jonasch E, Andrews L, Staehler M. Larkin J, et al. Among authors: pyle l. Am J Clin Oncol. 2014 Aug;37(4):397-403. doi: 10.1097/COC.0b013e31827b45f9. Am J Clin Oncol. 2014. PMID: 23357974

2

Sunitinib is superior to interferon alpha with respect to quality of life for patients with renal cell carcinoma.

Pickering LM, Pyle L, Larkin JM. Pickering LM, et al. Among authors: pyle l. Nat Clin Pract Oncol. 2009 Jan;6(1):6-7. doi: 10.1038/ncponc1283. Nat Clin Pract Oncol. 2009. PMID: 19096396

3

Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial.

Rini BI, Dorff TB, Elson P, Rodriguez CS, Shepard D, Wood L, Humbert J, Pyle L, Wong YN, Finke JH, Rayman PA, Larkin JM, Garcia JA, Plimack ER. Rini BI, et al. Among authors: pyle l. Lancet Oncol. 2016 Sep;17(9):1317-24. doi: 10.1016/S1470-2045(16)30196-6. Epub 2016 Aug 3. Lancet Oncol. 2016. PMID: 27498080 Free PMC article. Clinical Trial.

4

Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma.

Waters JS, Moss C, Pyle L, James M, Hackett S, A'hern R, Gore M, Eisen T. Waters JS, et al. Among authors: pyle l. Br J Cancer. 2004 Nov 15;91(10):1763-8. doi: 10.1038/sj.bjc.6602209. Br J Cancer. 2004. PMID: 15505625 Free PMC article. Clinical Trial.

5

The treatment of advanced renal cell cancer with high-dose oral thalidomide.

Stebbing J, Benson C, Eisen T, Pyle L, Smalley K, Bridle H, Mak I, Sapunar F, Ahern R, Gore ME. Stebbing J, et al. Among authors: pyle l. Br J Cancer. 2001 Sep 28;85(7):953-8. doi: 10.1054/bjoc.2001.2025. Br J Cancer. 2001. PMID: 11592764 Free PMC article. Clinical Trial.

6

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer.

Eisen T, Boshoff C, Mak I, Sapunar F, Vaughan MM, Pyle L, Johnston SR, Ahern R, Smith IE, Gore ME. Eisen T, et al. Among authors: pyle l. Br J Cancer. 2000 Feb;82(4):812-7. doi: 10.1054/bjoc.1999.1004. Br J Cancer. 2000. PMID: 10732751 Free PMC article. Clinical Trial.

7

A report of succinate dehydrogenase B deficiency associated with metastatic papillary renal cell carcinoma: successful treatment with the multi-targeted tyrosine kinase inhibitor sunitinib.

Tuthill M, Barod R, Pyle L, Cook T, Chew S, Gore M, Maxwell P, Eisen T. Tuthill M, et al. Among authors: pyle l. BMJ Case Rep. 2009;2009:bcr08.2008.0732. doi: 10.1136/bcr.08.2008.0732. Epub 2009 Feb 16. BMJ Case Rep. 2009. PMID: 21686655 Free PMC article.

8

A phase I pharmacokinetic and pharmacodynamic study of BGC9331 and carboplatin in relapsed gynaecological malignancies.

Benepal T, Jackman A, Pyle L, Bate S, Hardcastle A, Aherne W, Mitchell F, Simmons L, Ruddle R, Raynaud F, Gore M. Benepal T, et al. Among authors: pyle l. Br J Cancer. 2005 Oct 17;93(8):868-75. doi: 10.1038/sj.bjc.6602811. Br J Cancer. 2005. PMID: 16222320 Free PMC article. Clinical Trial.

9

A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer.

Gibbs DD, Pyle L, Allen M, Vaughan M, Webb A, Johnston SR, Gore ME. Gibbs DD, et al. Among authors: pyle l. Br J Cancer. 2002 May 6;86(9):1379-84. doi: 10.1038/sj.bjc.6600250. Br J Cancer. 2002. PMID: 11986767 Free PMC article. Clinical Trial.

10

Day in the life.

Pyle L. Pyle L. Nurs Times. 2002 Sep 24-30;98(39):48. Nurs Times. 2002. PMID: 12374014 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters